FDA regulatory affairs:
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
Boca Raton
Taylor & Francis
2014
|
Schlagworte: | |
Online-Zugang: | TUM01 Volltext |
Beschreibung: | Includes bibliographical references and index Overview of FDA and drug development / Josephine C. Babiarz and Douglas Pisano -- What is an IND? / Michael R. Hamrell -- The new drug application / Charles Monahan and Josephine C. Babiarz -- Meetings with the FDA / Alberto Grignolo and Sally Choe -- FDA medical device regulation / Barry Sall -- A primer of drug/device law : what is the law and how do I find it? / Josephine C. Babiarz -- The development of orphan drugs / Scott N. Freeman -- CMC sections of regulatory filings and CMC regulatory -- Compliance during investigational and postapproval stages / Prabu Nambiar, Steven R. Koepke, and Kevin Swiss -- Overview of the gxps for the regulatory professional / Bob Buckley, Robert Blanks, Kimberly J. White, and Tonya White-Salters -- FDA regulation of the advertising and promotion of prescription drugs, biologics, and medical devices / Karen L. Drake -- The practice of regulatory affairs / David S. Mantus -- FDA advisory / Christina A. McCarthy and David S. Mantus -- Biologics / Florence Kaltovich -- Regulation of combination products in the United States / John Barlow Weiner |
Beschreibung: | 1 Online-Ressource |
ISBN: | 1841849197 1841849200 9781841849195 9781841849201 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV041989814 | ||
003 | DE-604 | ||
005 | 20150527 | ||
007 | cr|uuu---uuuuu | ||
008 | 140723s2014 |||| o||u| ||||||eng d | ||
020 | |a 1841849197 |9 1-84184-919-7 | ||
020 | |a 1841849200 |c electronic bk. |9 1-84184-920-0 | ||
020 | |a 9781841849195 |9 978-1-84184-919-5 | ||
020 | |a 9781841849201 |c electronic bk. |9 978-1-84184-920-1 | ||
035 | |a (OCoLC)869462369 | ||
035 | |a (DE-599)BVBBV041989814 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-91 | ||
082 | 0 | |a 615/.19 |2 23 | |
245 | 1 | 0 | |a FDA regulatory affairs |c editors, Douglas J. Pisano, David Mantus |
264 | 1 | |a Boca Raton |b Taylor & Francis |c 2014 | |
300 | |a 1 Online-Ressource | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Includes bibliographical references and index | ||
500 | |a Overview of FDA and drug development / Josephine C. Babiarz and Douglas Pisano -- What is an IND? / Michael R. Hamrell -- The new drug application / Charles Monahan and Josephine C. Babiarz -- Meetings with the FDA / Alberto Grignolo and Sally Choe -- FDA medical device regulation / Barry Sall -- A primer of drug/device law : what is the law and how do I find it? / Josephine C. Babiarz -- The development of orphan drugs / Scott N. Freeman -- CMC sections of regulatory filings and CMC regulatory -- Compliance during investigational and postapproval stages / Prabu Nambiar, Steven R. Koepke, and Kevin Swiss -- Overview of the gxps for the regulatory professional / Bob Buckley, Robert Blanks, Kimberly J. White, and Tonya White-Salters -- FDA regulation of the advertising and promotion of prescription drugs, biologics, and medical devices / Karen L. Drake -- The practice of regulatory affairs / David S. Mantus -- FDA advisory / Christina A. McCarthy and David S. Mantus -- Biologics / Florence Kaltovich -- Regulation of combination products in the United States / John Barlow Weiner | ||
610 | 1 | 4 | |a United States / Food and Drug Administration |
650 | 4 | |a Drug Approval / United States | |
650 | 4 | |a United States Government Agencies / United States | |
650 | 4 | |a Biological Products / standards / United States | |
650 | 4 | |a Equipment and Supplies / standards / United States | |
650 | 4 | |a Government Regulation / United States | |
650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
650 | 4 | |a Medizin | |
650 | 4 | |a Drug development | |
651 | 4 | |a USA | |
700 | 1 | |a Pisano, Douglas J. |e Sonstige |4 oth | |
700 | 1 | |a Mantus, David |e Sonstige |4 oth | |
856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=686544 |x Aggregator |3 Volltext |
912 | |a ZDB-4-NLEBK | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-027432070 | ||
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=686544 |l TUM01 |p ZDB-4-NLEBK |q TUM_PDA_EBSCO_MED_gekauft |x Aggregator |3 Volltext |
Datensatz im Suchindex
_version_ | 1804152394421895168 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV041989814 |
collection | ZDB-4-NLEBK |
ctrlnum | (OCoLC)869462369 (DE-599)BVBBV041989814 |
dewey-full | 615/.19 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.19 |
dewey-search | 615/.19 |
dewey-sort | 3615 219 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02959nmm a2200493zc 4500</leader><controlfield tag="001">BV041989814</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20150527 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">140723s2014 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1841849197</subfield><subfield code="9">1-84184-919-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1841849200</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">1-84184-920-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781841849195</subfield><subfield code="9">978-1-84184-919-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781841849201</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-84184-920-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)869462369</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV041989814</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">FDA regulatory affairs</subfield><subfield code="c">editors, Douglas J. Pisano, David Mantus</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton</subfield><subfield code="b">Taylor & Francis</subfield><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Overview of FDA and drug development / Josephine C. Babiarz and Douglas Pisano -- What is an IND? / Michael R. Hamrell -- The new drug application / Charles Monahan and Josephine C. Babiarz -- Meetings with the FDA / Alberto Grignolo and Sally Choe -- FDA medical device regulation / Barry Sall -- A primer of drug/device law : what is the law and how do I find it? / Josephine C. Babiarz -- The development of orphan drugs / Scott N. Freeman -- CMC sections of regulatory filings and CMC regulatory -- Compliance during investigational and postapproval stages / Prabu Nambiar, Steven R. Koepke, and Kevin Swiss -- Overview of the gxps for the regulatory professional / Bob Buckley, Robert Blanks, Kimberly J. White, and Tonya White-Salters -- FDA regulation of the advertising and promotion of prescription drugs, biologics, and medical devices / Karen L. Drake -- The practice of regulatory affairs / David S. Mantus -- FDA advisory / Christina A. McCarthy and David S. Mantus -- Biologics / Florence Kaltovich -- Regulation of combination products in the United States / John Barlow Weiner</subfield></datafield><datafield tag="610" ind1="1" ind2="4"><subfield code="a">United States / Food and Drug Administration</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">United States Government Agencies / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological Products / standards / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Equipment and Supplies / standards / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Government Regulation / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pisano, Douglas J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mantus, David</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=686544</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027432070</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=686544</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-4-NLEBK</subfield><subfield code="q">TUM_PDA_EBSCO_MED_gekauft</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
geographic | USA |
geographic_facet | USA |
id | DE-604.BV041989814 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T01:10:01Z |
institution | BVB |
isbn | 1841849197 1841849200 9781841849195 9781841849201 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027432070 |
oclc_num | 869462369 |
open_access_boolean | |
owner | DE-91 DE-BY-TUM |
owner_facet | DE-91 DE-BY-TUM |
physical | 1 Online-Ressource |
psigel | ZDB-4-NLEBK ZDB-4-NLEBK TUM_PDA_EBSCO_MED_gekauft |
publishDate | 2014 |
publishDateSearch | 2014 |
publishDateSort | 2014 |
publisher | Taylor & Francis |
record_format | marc |
spelling | FDA regulatory affairs editors, Douglas J. Pisano, David Mantus Boca Raton Taylor & Francis 2014 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index Overview of FDA and drug development / Josephine C. Babiarz and Douglas Pisano -- What is an IND? / Michael R. Hamrell -- The new drug application / Charles Monahan and Josephine C. Babiarz -- Meetings with the FDA / Alberto Grignolo and Sally Choe -- FDA medical device regulation / Barry Sall -- A primer of drug/device law : what is the law and how do I find it? / Josephine C. Babiarz -- The development of orphan drugs / Scott N. Freeman -- CMC sections of regulatory filings and CMC regulatory -- Compliance during investigational and postapproval stages / Prabu Nambiar, Steven R. Koepke, and Kevin Swiss -- Overview of the gxps for the regulatory professional / Bob Buckley, Robert Blanks, Kimberly J. White, and Tonya White-Salters -- FDA regulation of the advertising and promotion of prescription drugs, biologics, and medical devices / Karen L. Drake -- The practice of regulatory affairs / David S. Mantus -- FDA advisory / Christina A. McCarthy and David S. Mantus -- Biologics / Florence Kaltovich -- Regulation of combination products in the United States / John Barlow Weiner United States / Food and Drug Administration Drug Approval / United States United States Government Agencies / United States Biological Products / standards / United States Equipment and Supplies / standards / United States Government Regulation / United States MEDICAL / Pharmacology bisacsh Medizin Drug development USA Pisano, Douglas J. Sonstige oth Mantus, David Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=686544 Aggregator Volltext |
spellingShingle | FDA regulatory affairs United States / Food and Drug Administration Drug Approval / United States United States Government Agencies / United States Biological Products / standards / United States Equipment and Supplies / standards / United States Government Regulation / United States MEDICAL / Pharmacology bisacsh Medizin Drug development |
title | FDA regulatory affairs |
title_auth | FDA regulatory affairs |
title_exact_search | FDA regulatory affairs |
title_full | FDA regulatory affairs editors, Douglas J. Pisano, David Mantus |
title_fullStr | FDA regulatory affairs editors, Douglas J. Pisano, David Mantus |
title_full_unstemmed | FDA regulatory affairs editors, Douglas J. Pisano, David Mantus |
title_short | FDA regulatory affairs |
title_sort | fda regulatory affairs |
topic | United States / Food and Drug Administration Drug Approval / United States United States Government Agencies / United States Biological Products / standards / United States Equipment and Supplies / standards / United States Government Regulation / United States MEDICAL / Pharmacology bisacsh Medizin Drug development |
topic_facet | United States / Food and Drug Administration Drug Approval / United States United States Government Agencies / United States Biological Products / standards / United States Equipment and Supplies / standards / United States Government Regulation / United States MEDICAL / Pharmacology Medizin Drug development USA |
url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=686544 |
work_keys_str_mv | AT pisanodouglasj fdaregulatoryaffairs AT mantusdavid fdaregulatoryaffairs |